Chardan Capital Initiates Coverage On Prothena Corp with Buy Rating, Announces Price Target of $40

Prothena Corp. Plc -2.35%

Prothena Corp. Plc

PRTA

13.74

-2.35%

Chardan Capital analyst Rudy Li initiates coverage on Prothena Corp (NASDAQ: PRTA) with a Buy rating and announces Price Target of $40.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via